Next Article in Journal
Coalescent-Based Species Delimitation in Herbaceous Bamboos (Bambusoideae, Olyreae) from Eastern Brazil: Implications for Taxonomy and Conservation in a Group with Weak Morphological Divergence Coupled with Low Genetic Diversity
Next Article in Special Issue
Kukoamine B from Lycii Radicis Cortex Protects Human Keratinocyte HaCaT Cells through Covalent Modification by Trans-2-Nonenal
Previous Article in Journal
Primary Root Excision Induces ERF071, Which Mediates the Development of Lateral Roots in Makapuno Coconut (Cocos nucifera)
Previous Article in Special Issue
Characterization of Neochloris oleoabundans under Different Cultivation Modes and First Results on Bioactivity of Its Extracts against HCoV-229E Virus
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Phytochemical Investigation of Marker Compounds from Indigenous Korean Salix Species and Their Antimicrobial Effects

1
School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea
2
Hongcheon Institute of Medicinal Herb, Hongcheon-gun 25142, Republic of Korea
3
Nakdonggang National Institute of Biological Resources, Sangju 37242, Republic of Korea
4
SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea
5
Department of Nano Engineering, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Plants 2023, 12(1), 104; https://doi.org/10.3390/plants12010104
Submission received: 18 November 2022 / Revised: 13 December 2022 / Accepted: 20 December 2022 / Published: 26 December 2022
(This article belongs to the Special Issue Research of Bioactive Substances in Plant Extracts II)

Abstract

:
Salix species, including willow trees, are distributed in the temperate regions of Asian countries, including South Korea. Willow trees are used to treat pain and inflammatory diseases. Due to the medicinal properties of willow trees, pharmacological studies of other Salix spp. have gained attention; however, only a few studies have investigated the phytochemicals of these species. As part of our ongoing natural product research to identify bioactive phytochemicals and elucidate their chemical structures from natural resources, we investigated the marker compounds from indigenous Korean Salix species, namely, Salix triandra, S. chaenomeloides, S. gracilistyla, S. koriyanagi, S. koreensis, S. pseudolasiogyne, S. caprea, and S. rorida. The ethanolic extract of each Salix sp. was investigated using high-performance liquid chromatography combined with thin-layer chromatography and liquid chromatography–mass spectrometry-based analysis, and marker compounds of each Salix sp. were isolated. The chemical structures of the marker compounds (1–8), 3-(4-hydroxyphenyl)propyl β-D-glucopyranoside (1), 2-O-acetylsalicin (2), 1-O-p-coumaroyl glucoside (3), picein (4), isograndidentatin B (5), 2′-O-acetylsalicortin (6), dihydromyricetin (7), and salicin (8) were elucidated via nuclear magnetic resonance spectroscopy and high-resolution liquid chromatography–mass spectrometry using ultrahigh-performance liquid chromatography coupled with a G6545B Q-TOF MS system with a dual electrospray ionization source. The identified marker compounds 1–8 were examined for their antimicrobial effects against plant pathogenic fungi and bacteria. Dihydromyricetin (7) exhibited antibacterial activity against Staphylococcus aureus, inducing 32.4% inhibition at a final concentration of 125 μg/mL with an MIC50 value of 250 μg/mL. Overall, this study isolated the marker compounds of S. triandra, S. chaenomeloides, S. gracilistyla, S. koriyanagi, S. koreensis, S. pseudolasiogyne, S. caprea, and S. rorida and identified the anti-Staphylococcus aureus bacterial compound dihydromyricetin.

1. Introduction

The genus Salix comprises approximately 500 species of deciduous trees and shrubs distributed in the temperate regions of Asian countries, including South Korea, and willow trees are the most representative plants of this genus [1]. Willow trees have been used for the treatment of pain and inflammatory diseases as their barks possess anti-inflammatory metabolites, such as salicylic acid, which is useful as a natural source of aspirin [2,3]. Owing to the use of willow trees for medicinal purposes, pharmacological studies of Salix spp. have gained attention, and many studies have demonstrated their biological and beneficial effects, including anti-inflammatory, antitumor, antioxidant, and antiobesity effects [4,5,6,7]. Specifically, salicin derivatives identified from Salix spp. exert anti-inflammatory effects by inhibiting lipopolysaccharide (LPS)-induced nitric oxide (NO) production in BV2 microglial cells [8].
Salix triandra, also known as almond willow, is native to Western and Central Asia and Europe. It is also used as a basket-making material. A pharmacological study of S. triandra reported that S. triandra leaf extract showed antioxidant activity by promoting the removal of 1,1-diphenyl-2-picrylhydrazyl (DPPH) [9]. Despite its health benefits, only a few studies have been conducted on the chemical constituents of S. triandra. S. chaenomeloides (also known as S. glandulosa), commonly called pussy willow, an indigenous plant found in East Asia. A previous phytochemical investigation of S. chaenomeloides reported the presence of phenolic glycosides and salicin derivatives [10,11], which showed inhibitory effects on NO production and anti-neuroinflammatory effects in LPS-activated murine microglial cells. S. gracilistyla is distributed along river coasts. Its stems and leaves are used in traditional medicine to treat skin diseases, wounds, and rooting arthritis, and its bark is used as a painkiller [12]. A pharmacological study of S. gracilistyla reported that the S. gracilistyla extract showed anti-inflammatory activity by inhibiting NO production in LPS-activated macrophages [13]. In addition, S. gracilistyla extracts can be used as effective cosmetic ingredients due to their antioxidant and skin-whitening activities [14]. However, only a few studies have been conducted on these phytochemicals. S. koriyanagi is found in fertile moist soil near rivers, streams, and valleys, and is generally called winnow willow, implying that the bark of this tree can be used to make winnowing baskets and traditional crafts [15]. S. koriyanagi is an endemic Korean species owing to its isolated distribution and high conservation priority [16], and few studies have investigated its pharmacological activities and phytochemicals. S. koreensis, also known as the Korean willow, grows along most rivers in Korea [17]. S. koreensis is traditionally used for brushing teeth after meals to clean the oral cavity and prevent oral inflammation and tooth decay [18]. A pharmacological study of S. koreensis reported that the S. koreensis extract showed anticancer activity by inhibiting cell growth and promoting apoptosis in human colon and lung cancer cells [19]. S. koreensis extract also showed antioxidant, anti-inflammatory, and hepatoprotective effects [20,21,22]. Despite its diverse pharmacological effects, only a few studies have investigated the chemical constituents of S. koreensis. S. pseudolasiogyne, also known as the weeping willow, is mostly found in Asian countries, including South Korea. It is used as a traditional Korean medicine for the treatment of pain and fever [23] Recent pharmacological studies have revealed that extracts of S. pseudolasiogyne twigs exert antiadipogenic and anti-amnesic effects [24,25]. Previous phytochemical investigations revealed salicin as the primary constituent of S. pseudolasiogyne twigs and reported salicin derivatives, such as 2′-O-acetylsalicin, salicortin, 2′-O-acetylsalicortin, 3′-O-acetylsalicortin, and 6′-O-acetylsalicortin, in S. pseudolasiogyne extracts [8,24]. S. caprea, also known as the goat willow, is mostly found in European and Asian countries, including South Korea. It is used in traditional Korean medicine for the treatment of pain and fever. Recent pharmacological studies have revealed that the EtOH extract of S. caprea flowers shows antioxidant activity to dose-dependently scavenge DPPH, superoxide (O2·−), and hydrogen peroxide (H2O2) [6] and that S. caprea extract inhibits 7,12-dimethyl benz[a] anthracene-induced phorbol ester-promoted skin carcinogenesis [4]. However, only a few phytochemical studies have focused on S. caprea. Finally, S. rorida is a deciduous tree and a willow species native to Japan, northern China, Korea, and Russia. A recent phytochemical study revealed salicin as the major constituent of S. rorida and identified other constituents, including (+)-catechin, naringenin, salipurposide, aromadendrin, isosalipurposide, aromadendrin-7-O-β-D-glucopyranoside, and taxifolin-7-O-β-D-glucopyranoside, via liquid chromatography–mass spectrometry (LC/MS) analysis [25]. However, the pharmacological activity of S. rorida has not yet been elucidated.
As part of our ongoing research projects to identify bioactive natural products and elucidate their chemical structures from natural resources [26,27,28,29,30,31,32], we investigated the marker compounds from the Korean indigenous Salix species S. triandra, S. chaenomeloides, S. gracilistyla, S. koriyanagi, S. koreensis, S. pseudolasiogyne, S. caprea, and S. rorida. Ethanolic extracts of these Salix spp. were investigated using high-performance liquid chromatography (HPLC) combined with thin-layer chromatography (TLC) and LC/MS-based analysis, followed by the isolation of each marker compound of Salix spp. The chemical structures of marker compounds (18) were elucidated via nuclear magnetic resonance (NMR) spectroscopy and electrospray ionization (ESI) LC/MS analyses. Finally, the identified marker compounds 18 were tested for their antimicrobial effects. Herein, we report the isolation and structural characterization of marker compounds 18 as well as their bioactivity with respect to their antimicrobial effects.

2. Results and Discussion

2.1. Collection of Salix Species

The twigs of eight Salix species (S. triandra, S. chaenomeloides, S. gracilistyla, S. koriyanagi, S. koreensis, S. pseudolasiogyne, S. caprea, and S. rorida) were collected from Chungcheongnam-do, Chungcheongbuk-do, and Gangwon-do (South Korea), thoroughly dried, and mounted. Plant specimens (Figure 1) were made into herbarium vouchers and stored at room temperature in the dark. Twigs of the collected Salix species were cut into small pieces and extracted with 80% ethanol (EtOH) to obtain EtOH crude extracts.

2.2. Isolation and Identification of Marker Compounds

Marker compounds are the pure or single isolated chemical constituents within a crude plant extract or medicinal herbal drug that can confirm the exact botanical identity of material. Marker compounds are of interest for quality control purposes; however, marker compounds may or may not contribute to the therapeutic activity of crude extracts or herbal drugs. Marker compounds can serve as active principals of the herbal drug in the preparation or the finished product. Marker compounds are applied at various stages in the development and manufacturing of herbal medicine, including authentication and differentiation of species, quality evaluation and stability assessment, and collecting and harvesting. LC/MS-based analysis combined with our in-house UV library and TLC analysis of crude EtOH extracts from the eight Salix species (S. triandra, S. chaenomeloides, S. gracilistyla, S. koriyanagi, S. koreensis, S. pseudolasiogyne, S. caprea, and S. rorida) facilitated the determination of the marker compounds for these species based on the amount of the component present in each extract. Phytochemical investigation of the crude EtOH extracts was performed via TLC and LC/MS-based analysis using column chromatography and HPLC to isolate the marker compounds (Figure 2). Final semipreparative HPLC separation revealed each marker compound from the fraction via LC/MS analysis, where 3-(4-hydroxyphenyl)propyl β-D-glucopyranoside (1) was isolated from S. triandra, 2-O-acetylsalicin (2) from S. chaenomeloides, 1-O-p-coumaroyl glucoside (3) from S. gracilistyla, picein (4) from S. koriyanagi, isograndidentatin B (5) from S. koreensis, 2′-O-acetylsalicortin (6) from S. pseudolasiogyne, dihydromyricetin (7) from S. caprea, and salicin (8) from S. rorida (Figure 3).
The marker compounds of Salix spp. were structurally elucidated as 3-(4-hydroxyphenyl)propyl β-D-glucopyranoside (1) [33], 2-O-acetylsalicin (2) [34], 1-O-p-coumaroyl glucoside (3) [35], picein (4) [36], isograndidentatin B (5) [37], 2′-O-acetylsalicortin (6) [38], dihydromyricetin (7) [39], and salicin (8) [40] (Figure 4) via NMR spectroscopy and high-resolution (HR)-ESI MS analysis (Figures S1–S16) using Agilent 1290 Infinity II ultrahigh-performance liquid chromatography coupled with a G6545B Q-TOF MS system with a dual ESI source.

2.3. Evaluation of the Antimicrobial Activities of the Marker Compounds

Plant diseases caused by fungi, bacteria, and viruses can cause significant damage to the yield and quality of crops, fruit, and vegetables. Synthetic pesticides are widely used to control plant diseases in agriculture. However, adverse effects of chronic exposure to synthetic chemicals and concerns about environmental pollution and pesticide resistance have prompted the need for the development of new ecofriendly plant protection agents [41,42]. Thus, the antifungal activities of all isolated marker compounds were evaluated against the plant pathogenic fungi, Fusarium solani, F. asiaticum, Botrytis cinerea, Cylindrocarpon destructans, and Rhizoctonia solani. Antifungal activity tests revealed that all tested compounds were inactive (data not shown). Next, the marker compounds were tested for their antibacterial activity against the Gram-positive bacterium Staphylococcus aureus (HG003) and Gram-negative bacterium Escherichia coli (MG1655). Among the isolates, only dihydromyricetin (7) exhibited antibacterial activity against S. aureus, inducing 32.4% inhibition at a final concentration of 125 μg/mL with an MIC50 value of 250 μg/mL (Table 1). Meanwhile, 3-(4-hydroxyphenyl)propyl β-D-glucopyranoside (1) and 1-O-p-coumaroyl glucoside (3) exhibited very weak activity against S. aureus, inducing only 1.9% and 1.3% inhibition, respectively (Table 1), and the other compounds had no effects on the growth of S. aureus and E. coli.

3. Materials and Methods

3.1. General Experimental Procedure

The experimental procedure is described in detail in Supplementary Materials.

3.2. Plant Materials

In June 2021, twigs of S. triandra were collected from Yesan-gun and those of S. pseudolasiogyne from Asan-si (Chungcheongnam-do, South Korea). Twigs of S. chaenomeloides, S. koriyanagi, and S. caprea were collected from Inje-gun and those of S. rorida from Hwacheon-gun (Gangwon-do, South Korea). The twigs of S. gracilistyla and S. koreensis were collected from Jecheon-si (Chungcheongbuk-do, South Korea). Each material was authenticated by the author J.N.Yu. Voucher specimens of the materials (HIMH-2104 for S. triandra, HIMH-2105 for S. chaenomeloides, HIMH-2106 for S. gracilistyla, HIMH-2107 for S. koriyanagi, HIMH-2108 for S. koreensis, HIMH-2109 for S. pseudolasiogyne, HIMH-2110 for S. caprea, and HIMH-2111 for S. rorida) were deposited at the Hongcheon Institute of Medicinal Herbs, Hongcheon-gun, South Korea.

3.3. Extraction and Isolation of Marker Compounds

3.3.1. S. triandra

S. triandra twigs (1.6 kg) were dried at 35–45 °C in a plant-drying oven for one week, pulverized, and extracted with 80% ethanol (10 L) via sonication for 90 min three times at room temperature. The filtered ethanol extract was evaporated in vacuo to obtain the crude ethanol extract (86.6 g). The extract (10.1 g) was dissolved in MeOH (100 mL) and applied to a reverse-phase (RP) Sep-Pak column with 100% MeOH to remove the wax, lipids, and fatty acids, and the resultant residue was concentrated using an evaporator to obtain the crude extract (5.2 g). The crude extract (1.0 g) was separated via preparative RP-HPLC (from 30 to 80% MeOH for 80 min, gradient system) to obtain four fractions (P1–P4). Fraction P2 (303.3 mg) was isolated via semipreparative RP-HPLC using 30% MeOH to obtain marker compound 1 (9.6 mg, tR = 44.0 min, ESI-MS [negative-ion mode] m/z 313 [M-H]).

3.3.2. S. chaenomeloides

S. chaenomeloides twigs (1.8 kg) were dried at 35–45 °C in a plant-drying oven for one week, pulverized, and extracted with 80% ethanol (10 L) via sonication for 90 min three times at room temperature. The filtered ethanol extract was evaporated in vacuo to obtain the crude ethanol extract (144.6 g). The extract (10.3 g) was dissolved in MeOH (100 mL) and applied to an RP Sep-Pak column with 100% MeOH to remove the wax, lipids, and fatty acids, and the resultant residue was concentrated using an evaporator to obtain the crude extract (7.2 g). The crude extract (1.0 g) was separated via preparative RP-HPLC (from 20 to 30% MeOH for 80 min, gradient system) to obtain five fractions (P1–P5). Fraction P4 (68.2 mg) was isolated via semipreparative RP-HPLC using 20% MeOH to obtain marker compound 2 (10.3 mg, tR = 48.0 min, ESI-MS [positive-ion mode] m/z 329 [M + H]+).

3.3.3. S. gracilistyla

S. gracilistyla twigs (1.0 kg) were dried at 35–45 °C in a plant-drying oven for one week, pulverized, and extracted with 80% ethanol (10 L) via sonication for 90 min three times at room temperature. The filtered ethanol extract was evaporated in vacuo to obtain the crude ethanol extract (163 g). The extract (11 g) was dissolved in MeOH (100 mL) and applied to an RP Sep-Pak column with 100% MeOH to remove the wax, lipids, and fatty acids, and the resultant residue was concentrated using an evaporator to obtain the crude extract (5.6 g). The crude extract (1.0 g) was separated via preparative RP-HPLC (from 20 to 30% MeOH for 80 min, gradient system) to obtain five fractions (P1–P5). Fraction P4 (468 mg) was isolated via semipreparative RP-HPLC using 23% MeOH to obtain marker compound 3 (9.8 mg, tR = 23.0 min, ESI-MS [negative-ion mode] m/z 325 [M-H]).

3.3.4. S. koriyanagi

S. koriyanagi twigs (2.0 kg) were dried at 35–45 °C in a plant-drying oven for one week, pulverized, and extracted with 80% ethanol (10 L) via sonication for 90 min three times at room temperature. The filtered ethanol extract was evaporated in vacuo to obtain the crude ethanol extract (167 g). The extract (10 g) was dissolved in MeOH (100 mL) and applied to an RP Sep-Pak column with 100% MeOH to remove the wax, lipids, and fatty acids, and the resultant residue was concentrated using an evaporator to obtain the crude extract (6.5 g). The crude extract (6.5 g) was subjected to HP-20 column chromatography, with eluting solvents of distilled water, MeOH, and acetone, to obtain three fractions (P1–P3). Fraction P1 (2.6 g) was separated via preparative RP-HPLC (from 20 to 30% MeOH for 82 min, gradient system) to obtain five fractions (P11–P15). Fraction P13 (245 mg) was isolated via semipreparative RP-HPLC using 15% MeOH to obtain marker compound 4 (10.5 mg, tR = 54.0 min, ESI-MS [negative-ion mode] m/z 297 [M-H]).

3.3.5. S. koreensis

S. koreensis twigs (2.3 kg) were dried at 35–45 °C in a plant-drying oven for one week, pulverized, and extracted with 80% ethanol (10 L) via sonication for 90 min three times at room temperature. The filtered ethanol extract was evaporated in vacuo to obtain the crude ethanol extract (101 g). The extract (9.1 g) was dissolved in MeOH (100 mL) and applied to an RP Sep-Pak column using 100% MeOH to remove the wax, lipids, and fatty acids, and the resultant residue was concentrated using an evaporator to obtain the crude extract (7.9 g). The crude extract (7.9 g) was subjected to HP-20 column chromatography, with the eluting solvents distilled water, MeOH, and acetone to obtain three fractions (P1–P3). Fraction P3 (582 mg) was separated via preparative RP-HPLC (from 20% to 100% MeOH for 101 min, gradient system) to obtain four fractions (P31–P34). Fraction P33 (582 mg) was isolated via semipreparative RP-HPLC using 43% MeOH to obtain marker compound 5 (11.5 mg, tR = 60.0 min, ESI-MS [positive-ion mode] m/z 447 [M + Na]+).

3.3.6. S. pseudolasiogyne

S. pseudolasiogyne twigs (1.5 kg) were dried at 35–45 °C in a plant-drying oven for one week, pulverized, and extracted with 80% ethanol (10 L) via sonication for 90 min three times at room temperature. The filtered ethanol extract was evaporated in vacuo to obtain the crude ethanol extract (123.6 g). The extract (9.1 g) was dissolved in MeOH (100 mL) and applied to an RP Sep-Pak column using 100% MeOH to remove the wax, lipids, and fatty acids, and the resultant residue was concentrated using an evaporator to obtain the crude extract (4.0 g). The crude extract (4.0 g) was separated via preparative RP-HPLC (from 30 to 50% MeOH for 81 min, gradient system) to obtain four fractions (P1–P4). Fraction P4 (306 mg) was isolated via semipreparative RP-HPLC using 39% MeOH to obtain marker compound 6 (11.2 mg, tR = 44.0 min, ESI-MS [positive-ion mode] m/z 467 [M + H]+).

3.3.7. S. caprea

S. caprea twigs (1.5 kg) were dried at 35–45℃ in a plant-drying oven for one week, pulverized, and extracted with 80% ethanol (10 L) via sonication for 90 min three times at room temperature. The filtered ethanol extract was evaporated in vacuo to obtain the crude ethanol extract (110.8 g). The crude extract (10.3 g) was separated using medium-pressure liquid chromatography (MPLC) (5%→10%→30%→100% MeOH, 92 min, gradient system) to yield seven fractions (P1–P7). Fraction P4 (507 mg) was isolated via semipreparative RP-HPLC using 27% MeOH to obtain marker compound 7 (11.8 mg, tR = 45.0 min, ESI-MS [positive-ion mode] m/z 321 [M + H]+).

3.3.8. S. rorida

S. rorida twigs (1.5 kg) were dried at 35–45 °C in a plant-drying oven for one week, pulverized, and extracted with 80% ethanol (10 L) via sonication for 90 min three times at room temperature. The filtered ethanol extract was evaporated in vacuo to obtain the crude ethanol extract (143.3 g). The extract (10.5 g) was dissolved in MeOH (100 mL) and applied to an RP Sep-Pak column with 100% MeOH to remove the wax, lipids, and fatty acids, and the resultant residue was concentrated using an evaporator to obtain the crude extract (7.8 g). The crude extract (7.8 g) was separated by MPLC (from 0% to 50% MeOH for 70 min, gradient system) to obtain four fractions (P1–P4). Fraction P2 (218 mg) was isolated via semipreparative RP-HPLC using 15% MeOH to obtain marker compound 8 (15.2 mg, tR = 38.0 min, ESI-MS [positive-ion mode] m/z 304 [M + NH4]+).

3.4. Antifungal Activity

Five plant pathogenic fungi provided by the Korean Agricultural Culture Collection (KACC; Jeonju, South Korea). B. cinerea (KACC40965), C. destructans (KACC 41077), F. solani (KACC 44891), F. asiaticum (KACC 46429), and R. solani (KACC 48921), were used for the in vitro antifungal activity assay. Fungi were cultivated on 25 mL of malt extract agar (Difco, MD, USA) at 25 °C for 14 d in the dark. Marker compounds (18) were evaluated for their antifungal activities in a 96-well microplate [42]. Each well of the 96-well microplate contained 2 μL of the compound, 20 μL of spore suspension, and 178 μL of medium. Chemical fungicide benomyl was used as a positive control and dimethyl sulfoxide (DMSO; 1%) was used as a negative control for the antifungal assay. The plant pathogenic fungal spore suspension was adjusted to a density of 4 × 106 cells/mL. The absorbance at 600 nm was measured every 12 h for 96 h. The experiments were performed in triplicate. The percentage of growth inhibition (GI%) was estimated using the following formula: GI% = 100 (Acontrol − Atest sample)/(Acontrol).

3.5. Antibacterial Activity

For the antibacterial activity assay, the Gram-positive bacterium S. aureus (HG033) and the Gram-negative bacterium E. coli (MG1655) were used. Staphylococcus aureus strains were maintained aerobically in tryptic soy broth (TSB, BD) or TSB 1.5% agar at 30 °C with shaking at 250 rpm. E. coli strains were maintained aerobically in lysogeny broth (LB, BD) or LB 1.5% agar at 37 °C with shaking at 250 rpm. The qualitative antibacterial activities of the marker compounds (18) were examined using the disk diffusion assay and MIC values [43]. The disk diffusion assay was performed in TSB and LB plates to examine the antibacterial activity for screening the marker compounds (18). The marker compounds were prepared in DMSO (1%) at 100 μg/mL (subinhibitory concentrations of 5, 10, 25, and 50 μg/mL). The assay was performed with LB and TSB plates. Sterile beads were used to inoculate the surface of each plate to ensure homogeneous bacterial growth. Sample pellet disks were placed on the surface of the agar plates at equal distances. The inhibition was measured using a ruler after 24 h incubation at 30 and 37 °C. MIC assay was performed in a 96-well plate to examine the antibacterial effects of three marker compounds (1, 3, and 7). Following serial dilution of the compounds (1, 3, and 7) in 150 μL of Mueller–Hinton broth, the culture was inoculated at an optical density (OD) of 0.002. After incubation at 30 and 37 °C for 24 h with shaking, bacterial growth was measured at OD600 using a spectrophotometer (BioTek Synergy HTX).

4. Conclusions

In the present study, indigenous Korean Salix species (S. triandra, S. chaenomeloides, S. gracilistyla, S. koriyanagi, S. koreensis, S. pseudolasiogyne, S. caprea, and S. rorida) were phytochemically investigated, followed by the isolation of their marker compounds: 3-(4-hydroxyphenyl)propyl β-D-glucopyranoside (1) from S. triandra, 2-O-acetylsalicin (2) from S. chaenomeloides, 1-O-p-coumaroyl glucoside (3) from S. gracilistyla, picein (4) from S. koriyanagi, isograndidentatin B (5) from S. koreensis, 2′-O-acetylsalicortin (6) from S. pseudolasiogyne, dihydromyricetin (7) from S. caprea, and salicin (8) from S. rorida. The chemical structures of these compounds were also determined via NMR spectroscopy and HR-ESI-MS analysis. Antimicrobial tests of the marker compounds (18) using plant pathogenic fungi and bacteria revealed that dihydromyricetin (7) exhibited antibacterial activity against S. aureus, inducing 32.4% inhibition at a final concentration of 125 μg/mL, with an MIC50 value of 250 μg/mL.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/plants12010104/s1. Figure S1: The 1H NMR spectrum of Compound 1 (CD3OD, 850 MHz); Figure S2: The HR-ESIMS data for Compound 1; Figure S3: The 1H NMR spectrum of Compound 2 (CD3OD, 850 MHz); Figure S4: The HR-ESIMS data for Compound 2; Figure S5: The 1H NMR spectrum of Compound 3 (DMSO-d6, 850 MHz); Figure S6: The HR-ESIMS data for Compound 3; Figure S7: The 1H NMR spectrum of Compound 4 (DMSO-d6, 850 MHz); Figure S8: The HR-ESIMS data for Compound 4; Figure S9: The 1H NMR spectrum of Compound 5 (CD3OD, 850 MHz); Figure S10: The HR-ESIMS data for Compound 5; Figure S11: The 1H NMR spectrum of Compound 6 (CD3OD, 850 MHz); Figure S12: The HR-ESIMS data for Compound 6; Figure S13: The 1H NMR spectrum of Compound 7 (DMSO-d6, 850 MHz); Figure S14: The HR-ESIMS data for Compound 7; Figure S15: The 1H NMR spectrum of Compound 8 (DMSO-d6, 850 MHz); Figure S16: The HR-ESIMS data for Compound 8.

Author Contributions

Conceptualization, S.A. and K.H.K.; formal analysis, Y.S.J., D.E.L., J.-H.H., K.A.K., B.K., Y.R.C., M.-J.R., S.-M.J. and J.-N.Y.; investigation, Y.S.J., D.E.L., J.-H.H., K.A.K., B.K. and Y.R.C.; writing—original draft preparation, Y.S.J., D.E.L. and K.H.K.; writing—review and editing, S.A. and K.H.K.; visualization, Y.S.J. and D.E.L.; supervision, S.A. and K.H.K.; project administration, S.A. and K.H.K.; funding acquisition, K.H.K. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT; 2019R1A5A2027340 and 2021R1A2C2007937) and the Korea Environment Industry and Technology Institute (KEITI) through a project to make multi-ministerial national biological research resources more advanced, funded by the Korea Ministry of Environment (MOE; 2021003420003).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mahdi, J.G.; Mahdi, A.J.; Mahdi, A.J.; Bowen, I.D. The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential. Cell Prolif. 2006, 39, 147–155. [Google Scholar] [CrossRef] [PubMed]
  2. Du, Q.; Jerz, G.; Shen, L.; Xiu, L.; Winterhalter, P. Isolation and structure determination of a lignan from the bark of Salix alba. Nat. Prod. Res. 2007, 21, 451–454. [Google Scholar] [CrossRef] [PubMed]
  3. Freischmidt, A.; Jurgenliemk, G.; Kraus, B.; Okpanyi, S.N.; Muller, J.; Kelber, O.; Weiser, D.; Heilmann, J. Contribution of flavonoids and catechol to the reduction of ICAM-1 expression in endothelial cells by a standardised Willow bark extract. Phytomedicine Int. J. Phytother. Phytopharm. 2012, 19, 245–252. [Google Scholar] [CrossRef]
  4. Sultana, S.; Saleem, M. Salix caprea inhibits skin carcinogenesis in murine skin: Inhibition of oxidative stress, ornithine decarboxylase activity and DNA synthesis. J. Ethnopharmacol. 2004, 91, 267–276. [Google Scholar] [CrossRef]
  5. Li, X.; Liu, Z.; Zhang, X.F.; Wang, L.J.; Zheng, Y.N.; Yuan, C.C.; Sun, G.Z. Isolation and characterization of phenolic compounds from the leaves of Salix matsudana. Molecules 2008, 13, 1530–1537. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Alam, M.S.; Kaur, G.; Jabbar, Z.; Javed, K.; Athar, M. Evaluation of antioxidant activity of Salix caprea flowers. Phytother. Res. PTR 2006, 20, 479–483. [Google Scholar] [CrossRef]
  7. Han, L.K.; Sumiyoshi, M.; Zhang, J.; Liu, M.X.; Zhang, X.F.; Zheng, Y.N.; Okuda, H.; Kimura, Y. Anti-obesity action of Salix matsudana leaves (Part 1). Anti-obesity action by polyphenols of Salix matsudana in high fat-diet treated rodent animals. Phytother. Res. PTR 2003, 17, 1188–1194. [Google Scholar] [CrossRef]
  8. Yang, H.; Lee, S.H.; Sung, S.H.; Kim, J.; Kim, Y.C. Neuroprotective compounds from Salix pseudo-lasiogyne twigs and their anti-amnesic effects on scopolamine-induced memory deficit in mice. Planta Med. 2013, 79, 78–82. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Gligorić, E.; Igić, R.; Suvajdžić, L.; Grujić-Letić, N. Species of the genus Salix L.: Biochemical screening and molecular docking approach to potential acetylcholinesterase inhibitors. Appl. Sci. 2019, 9, 1842. [Google Scholar] [CrossRef] [Green Version]
  10. Kim, C.S.; Subedi, L.; Park, K.J.; Kim, S.Y.; Choi, S.U.; Kim, K.H.; Lee, K.R. Salicin derivatives from Salix glandulosa and their biological activities. Fitoterapia 2015, 106, 147–152. [Google Scholar] [CrossRef]
  11. Kim, C.S.; Kwon, O.W.; Kim, S.Y.; Choi, S.U.; Kim, J.Y.; Han, J.Y.; Lee, K.R. Phenolic glycosides from the twigs of Salix glandulosa. J. Nat. Prod. 2014, 77, 1955–1961. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Jeong, Y.U.; Park, Y.J. Effect of Ganoderma lucidum Solid-state Fermented Salix gracilistyla Extract on Type I Procollagen Biosynthesis in HDFn Cells. Korean J. Mycol. 2019, 47, 153–163. [Google Scholar] [CrossRef]
  13. Ryu, J.H.; Ahn, H.; Kim, J.Y.; Kim, Y.K. Inhibitory activity of plant extracts on nitric oxide synthesis in LPS-activated macrophages. Phytother. Res. 2003, 17, 485–489. [Google Scholar] [CrossRef] [PubMed]
  14. Jeong, Y.-U.; Park, Y.-J. Studies on antioxidant and whitening activities of Salix gracilistyla extracts. J. Soc. Cosmet. Sci. Korea 2018, 44, 317–325. [Google Scholar] [CrossRef]
  15. Jung, B.N.; Park, J.H.; Shin, H.D. First report of Rhytisma filamentosum causing tar-spot disease on Salix koriyanagi. For. Pathol. 2020, 50, e12577. [Google Scholar] [CrossRef]
  16. Yoon, A.; Oh, H.E.; Kim, S.Y.; Park, Y.G. Plant growth regulators and rooting substrates affect growth and development of Salix koriyanagi cuttings. Rhizosphere 2021, 20, 100437. [Google Scholar] [CrossRef]
  17. Ahn, Y.; Yang, Y.; Chun, S. A study on the distribution patterns of Salicaceae species at the An-sung stream-refered to Woldongcheon, Yokjungcheon, Joyoungcheon and Gisolcheon. Kor. J. Env. Eco 2001, 15, 213–223. [Google Scholar]
  18. Park, Y. A study about control of gingivitis and plaque of dentifrice containing tranexamic acid and willow tree bark. J Korean Acad. Dent. Health 2006, 30, 271–279. [Google Scholar] [CrossRef]
  19. Hostanska, K.; Jürgenliemk, G.; Abel, G.; Nahrstedt, A.; Saller, R. Willow bark extract (BNO1455) and its fractions suppress growth and induce apoptosis in human colon and lung cancer cells. Cancer Detect. Prev. 2007, 31, 129–139. [Google Scholar] [CrossRef]
  20. Kim, E.-J.; Kim, M.H. Anti-oxidant and anti-inflammatory effects of Salix koreensis Andersson in DC. leaf methanol extract in vitro models. CELLMED 2016, 6, 28.21–28.26. [Google Scholar] [CrossRef] [Green Version]
  21. Kim, M.H. Antioxidant activity and anti-inflammatory effects of Salix Koreensis Andersson branches extracts. J. Korean Soc. Food Cult. 2018, 33, 104–111. [Google Scholar] [CrossRef]
  22. Kim, S.; Min, J.; Kang, H. Hepatoprotective effects of willow (Salix koreensis ANDERSS.) branch extracts against cytotoxicity induced by tert-butyl hydroperoxide in human hepatoma cells. J. Korean Soc. Food Sci. Nutr. 2020, 49, 1328–1334. [Google Scholar] [CrossRef]
  23. Ko, K.S.; Jeon, E.S. Fern-Allies and Seed-Bearing Plants of Korea; Iljinsa: Seoul, Republic of Korea, 2003; pp. 17–18. [Google Scholar]
  24. Lee, M.; Lee, S.H.; Kang, J.; Yang, H.; Jeong, E.J.; Kim, H.P.; Sung, S.H. Salicortin-derivatives from Salix pseudo-lasiogyne twigs inhibit adipogenesis in 3T3-L1 cells via modulation of C/EBPα and SREBP1c dependent pathway. Molecules 2013, 18, 10484–10496. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Noleto-Dias, C.; Ward, J.L.; Bellisai, A.; Lomax, C.; Beale, M.H. Salicin-7-sulfate: A new salicinoid from willow and implications for herbal medicine. Fitoterapia 2018, 127, 166–172. [Google Scholar] [CrossRef]
  26. Lee, S.R.; Kang, H.; Yoo, M.J.; Yu, J.S.; Lee, S.; Yi, S.A.; Beemelmanns, C.; Lee, J.; Kim, K.H. Anti-adipogenic pregnane steroid from a Hydractinia-associated fungus, Cladosporium sphaerospermum SW67. Nat. Prod. Sci. 2020, 26, 230–235. [Google Scholar] [CrossRef]
  27. Yu, J.S.; Park, M.; Pang, C.; Rashan, L.; Jung, W.H.; Kim, K.H. Antifungal phenols from Woodfordia uniflora collected in Oman. J. Nat. Prod. 2020, 83, 2261–2268. [Google Scholar] [CrossRef]
  28. Lee, S.; Kim, C.S.; Yu, J.S.; Kang, H.; Yoo, M.J.; Youn, U.J.; Ryoo, R.; Bae, H.Y.; Kim, K.H. Ergopyrone, a Styrylpyrone-Fused Steroid with a Hexacyclic 6/5/6/6/6/5 Skeleton from a Mushroom Gymnopilus orientispectabilis. Org. Lett. 2021, 23, 3315–3319. [Google Scholar] [CrossRef]
  29. Lee, K.H.; Kim, J.K.; Yu, J.S.; Jeong, S.Y.; Choi, J.H.; Kim, J.C.; Ko, Y.J.; Kim, S.H.; Kim, K.H. Ginkwanghols A and B, osteogenic coumaric acid-aliphatic alcohol hybrids from the leaves of Ginkgo biloba. Arch. Pharmacal Res. 2021, 44, 514–524. [Google Scholar] [CrossRef]
  30. Yu, J.S.; Li, C.; Kwon, M.; Oh, T.; Lee, T.H.; Kim, D.H.; Ahn, J.S.; Ko, S.-K.; Kim, C.S.; Cao, S. Herqueilenone A, a unique rearranged benzoquinone-chromanone from the hawaiian volcanic soil-associated fungal strain Penicillium herquei FT729. Bioorg. Chem. 2020, 105, 104397. [Google Scholar] [CrossRef]
  31. Ha, J.W.; Kim, J.; Kim, H.; Jang, W.; Kim, K.H. Mushrooms: An important source of natural bioactive compounds. Nat. Prod. Sci. 2020, 26, 118–131. [Google Scholar] [CrossRef]
  32. Lee, S.; Ryoo, R.; Choi, J.H.; Kim, J.-H.; Kim, S.-H.; Kim, K.H. Trichothecene and tremulane sesquiterpenes from a hallucinogenic mushroom Gymnopilus junonius and their cytotoxicity. Arch. Pharm. Res. 2020, 43, 214–223. [Google Scholar] [CrossRef] [PubMed]
  33. Akita, H.; Kawahara, E.; Kishida, M.; Kato, K. Synthesis of naturally occurring β-D-glucopyranoside based on enzymatic β-glycosidation. J. Mol. Catal. B Enzym. 2006, 40, 8–15. [Google Scholar] [CrossRef]
  34. Tawfeek, N.; Sobeh, M.; Hamdan, D.I.; Farrag, N.; Roxo, M.; El-Shazly, A.M.; Wink, M. Phenolic compounds from Populus alba L. and Salix subserrata Willd. (Salicaceae) counteract oxidative stress in Caenorhabditis elegans. Molecules 2019, 24, 1999. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Whang, W.K.; Chang, Y.S.; Kim, I.H. Phenolic compounds from the bark of Salix Gilgiana. Yakhak Hoeji 1995, 39, 193–199. [Google Scholar]
  36. Jeon, S.H.; Chun, W.; Choi, Y.J.; Kwon, Y.S. Cytotoxic constituents from the bark of Salix hulteni. Arch. Pharmacal Res. 2008, 31, 978–982. [Google Scholar] [CrossRef]
  37. Si, C.L.; Kim, J.K.; Bae, Y.S.; Li, S.M. Phenolic compounds in the leaves of Populus ussuriensis and their antioxidant activities. Planta Med. 2009, 75, 1165–1167. [Google Scholar] [CrossRef]
  38. Reichardt, P.B.; Merken, H.M.; Clausen, T.P.; Wu, J. Phenolic glycosides from Salix lasiandra. Journal of Natural Products. J. Nat. Prod. 1992, 55, 970–973. [Google Scholar] [CrossRef]
  39. Du, Q.; Cai, W.; Xia, M.; Ito, Y. Purification of (+)-dihydromyricetin from leaves extract of Ampelopsis grossedentata using high-speed countercurrent chromatograph with scale-up triple columns. J. Chromatogr. A 2002, 973, 217–220. [Google Scholar] [CrossRef]
  40. Lindroth, R.L.; Hsia, M.S.; Scriber, J.M. Characterization of phenolic glycosides from quaking aspen. Biochem. Syst. Ecol. 1987, 15, 677–680. [Google Scholar] [CrossRef]
  41. Choi, G.J.; Jang, K.S.; Choi, Y.H.; Yu, J.H.; Kim, J.C. Antifungal activity of lower alkyl fatty acid esters against powdery mildews. Plant Pathol. J. 2010, 26, 360–366. [Google Scholar] [CrossRef]
  42. Hong, J.H.; Lee, J.; Min, M.; Ryu, S.M.; Lee, D.; Kim, G.H.; Kim, J.J. 6-Pentyl-α-pyrone as an anti-sapstain compound produced by Trichoderma gamsii KUC1747 inhibits the germination of ophiostomatoid fungi. Holzforschung 2014, 68, 769–774. [Google Scholar] [CrossRef]
  43. Yu, J.S.; Kim, J.H.; Rashan, L.; Kim, I.; Lee, W.; Kim, K.H. Potential Antimicrobial Activity of Galloyl-Flavonoid glycosides From Woodfordia uniflora Against Methicillin-Resistant Staphylococcus aureus. Front. Microbiol. 2021, 12, 784504. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Specimens of the eight collected Salix species (S. triandra, S. chaenomeloides, S. gracilistyla, S. koriyanagi, S. koreensis, S. pseudolasiogyne, S. caprea, and S. rorida).
Figure 1. Specimens of the eight collected Salix species (S. triandra, S. chaenomeloides, S. gracilistyla, S. koriyanagi, S. koreensis, S. pseudolasiogyne, S. caprea, and S. rorida).
Plants 12 00104 g001
Figure 2. Separation scheme of the marker compounds 18.
Figure 2. Separation scheme of the marker compounds 18.
Plants 12 00104 g002
Figure 3. HPLC chromatogram for isolation of marker compounds 1–8 from the eight collected Salix species.
Figure 3. HPLC chromatogram for isolation of marker compounds 1–8 from the eight collected Salix species.
Plants 12 00104 g003
Figure 4. Chemical structures of the marker compounds 1–8.
Figure 4. Chemical structures of the marker compounds 1–8.
Plants 12 00104 g004
Table 1. Antibacterial activities of the selected marker compounds 1, 3, and 7 against Staphylococcus aureus.
Table 1. Antibacterial activities of the selected marker compounds 1, 3, and 7 against Staphylococcus aureus.
CompoundConcentration (μg/mL)Inhibition (%)MIC50 (μg/mL)MIC90 (μg/mL)
11251.9
31.3
732.4250500
Gentamicin a7.896.51.953.91
a Positive control.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jang, Y.S.; Lee, D.E.; Hong, J.-H.; Kim, K.A.; Kim, B.; Cho, Y.R.; Ra, M.-J.; Jung, S.-M.; Yu, J.-N.; An, S.; et al. Phytochemical Investigation of Marker Compounds from Indigenous Korean Salix Species and Their Antimicrobial Effects. Plants 2023, 12, 104. https://doi.org/10.3390/plants12010104

AMA Style

Jang YS, Lee DE, Hong J-H, Kim KA, Kim B, Cho YR, Ra M-J, Jung S-M, Yu J-N, An S, et al. Phytochemical Investigation of Marker Compounds from Indigenous Korean Salix Species and Their Antimicrobial Effects. Plants. 2023; 12(1):104. https://doi.org/10.3390/plants12010104

Chicago/Turabian Style

Jang, Yoon Seo, Da Eun Lee, Joo-Hyun Hong, Kyung Ah Kim, Bora Kim, Yeo Rang Cho, Moon-Jin Ra, Sang-Mi Jung, Jeong-Nam Yu, Seongpil An, and et al. 2023. "Phytochemical Investigation of Marker Compounds from Indigenous Korean Salix Species and Their Antimicrobial Effects" Plants 12, no. 1: 104. https://doi.org/10.3390/plants12010104

APA Style

Jang, Y. S., Lee, D. E., Hong, J. -H., Kim, K. A., Kim, B., Cho, Y. R., Ra, M. -J., Jung, S. -M., Yu, J. -N., An, S., & Kim, K. H. (2023). Phytochemical Investigation of Marker Compounds from Indigenous Korean Salix Species and Their Antimicrobial Effects. Plants, 12(1), 104. https://doi.org/10.3390/plants12010104

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop